Literature DB >> 1666324

Indications for the use of cytomegalovirus-seronegative blood products.

J K Preiksaitis1.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1666324     DOI: 10.1016/s0887-7963(91)70189-2

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


× No keyword cloud information.
  3 in total

Review 1.  The immunocompromised patient and transfusion.

Authors:  K G Badami
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Blood transfusion and haemostatic management in the perioperative period.

Authors:  A J McIntyre
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

Review 3.  Blood transfusion in newborn.

Authors:  M Mahapatra; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.